What is prostate cancer ? Cancer is a disease in which cells in the body grow out of control. Prostate cancer begins in the cells of the prostate . The ...
This page contains affiliate links. If you click a link and make a purchase or sign up for a service, Online Health Directory may earn a commission at no additional cost to you. We only recommend services we believe provide genuine value. For full details, see our Affiliate Disclosure page.
What is prostate cancer ? Cancer is a disease in which cells in the body grow out of control. Prostate cancer begins in the cells of the prostate. The prostate is a gland in the male reproductive system. It lies just below the bladder. It makes fluid that is part of semen. Prostate cancer is one of the most common types of cancer . It often grows very slowly. If it does not spread to other parts of the body, it may not cause serious problems. But sometimes prostate cancer can grow quickly and spread to other parts of the body. This kind of prostate cancer is serious. What causes prostate cancer ? Researchers don't know for sure what causes prostate cancer . They do know that it happens when there are changes in the genetic material (DNA). Sometimes these genetic changes are inherited, meaning that you are born with them. There are also certain genetic changes that happen during your lifetime that can raise your risk of prostate cancer . But often the exact cause of these genetic changes is unknown. Who is more likely to develop prostate cancer ? Anyone who has a prostate can develop prostate cancer . But certain factors can make you more likely to develop it: Age. Your chance of developing prostate cancer increases as you get older. Prostate cancer is rare in people under age 50. Family health history. Your risk of prostate cancer is higher if you have a parent, sibling, or child who has or has had prostate cancer . Race. African Americans are more likely to get prostate cancer . They're also more likely to: Get prostate cancer at a younger age. Have more serious prostate cancer . Die from prostate cancer . What are the symptoms of prostate cancer ? Prostate cancer doesn't always cause symptoms, especially at first. If it does cause symptoms, they may include: Problems urinating (peeing), such as: A urine stream that's weak, hard to start, or starts and stops Suddenly needing to urinate right away Urinating often, especially at night Pain or burning when urinating Blood in your urine or semen Pain in your lower back, hips, or pelvis that does not go away Painful ejaculation (the release of semen through the penis during orgasm) But many of these symptoms may be from other common prostate problems that aren't cancer , such as an enlarged prostate . You should discuss your prostate health with your health care provider if you: Have symptoms that could be prostate cancer Have a high risk for developing prostate cancer Had a screening test that suggests you could have prostate cancer What are prostate tests and how is prostate cancer diagnosed? Tests which check for prostate cancer include: A digital rectal exam (DRE). In this exam, your provider feels your prostate for lumps or anything unusual by inserting a lubricated, gloved finger into your rectum. A prostate -specific antigen (PSA) blood test. A high PSA blood level may be a sign of prostate cancer . But many other things can cause high PSA levels, too. Imaging tests. These tests may use ultrasound or MRI to make pictures of your prostate . If these tests show that you might have prostate cancer , the next step is usually a prostate biopsy. A biopsy is the only way to diagnose prostate cancer . During a biopsy, a doctor uses a hollow needle to remove some prostate tissue. The tissue is studied under a microscope to look for cancer cells. What are the treatments for prostate cancer ? Your treatment options usually depend on your age, your general health, and how serious the cancer is. Your treatment may include one or more options: Observation,which is mostly used if you are older, your prostate cancer isn't likely to grow quickly, and you don't have symptoms or you have other medical conditions. Your doctor will keep checking on your cancer over time so to see whether you will need to start treatment for the cancer . There are two types of observation: Watchful waiting means having little or no testing. If symptoms begin or change, you will get treatment to relieve them, but not to treat the cancer . Active surveillance means having regular tests to see if your prostate cancer has changed. If the tests show the cancer is starting to grow or if you develop symptoms, then you will have treatment to try to cure the cancer . Surgery to remove your prostate gland may be an option if your cancer hasn't spread outside of your prostate . Radiation therapy uses high energy to kill cancer cells or prevent them from growing. Hormone therapy blocks cancer cells from getting the hormones they need to grow. It may include taking medicines or having surgery to remove the testicles. Chemotherapy uses medicines to kill cancer cells, slow their growth, or stop them from spreading. You might take the drugs by mouth, as an injection (shot), as a cream, or intravenously (by IV). Targeted therapy uses drugs or other substances that attack specific cancer cells. This treatment causes less harm to healthy cells than radiation therapy or chemotherapy. Immunotherapy helps your own immune system to fight cancer . Can prostate cancer be prevented? Making healthy lifestyle changes may help to prevent some prostate cancers . These changes include: Being at a healthy weight Quitting smoking Getting enough exercise Eating healthy foods NIH: National Cancer Institute Health topic information sourced from MedlinePlus, a service of the National Library of Medicine, National Institutes of Health.
Health topic information on this page is sourced from MedlinePlus, a service of the National Library of Medicine, National Institutes of Health. Visit medlineplus.gov for more information.
FDA-approved medications commonly prescribed for prostate cancer. This is not medical advice — a clinician decides which treatment fits your situation.
1 INDICATIONS AND USAGE Zoledronic Acid Injection is a bisphosphonate indicated for the treatment of: Hypercalcemia of malignancy ( 1.1 ) Patients with multiple myeloma and patients with documented bone metastases from solid tumors, in conjunction with standard antineoplastic therapy. Prostate cancer should have progressed after treatment with at least one hormonal therapy ( 1.2 ) Important limitation of use: The safety and efficacy of Zoledronic Acid Injection has not been established for use…
5 WARNINGS AND PRECAUTIONS Patients being treated with Zoledronic Acid Injection should not be treated with Reclast ® . ( 5.1 ) Adequately rehydrate patients with hypercalcemia of malignancy prior to administration of Zoledronic Acid Injection and monitor electrolytes during treatment. ( 5.2 )…
1 INDICATIONS AND USAGE VABRINTY is indicated for the treatment of advanced prostate cancer. VABRINTY is a gonadotropin releasing hormone (GnRH) agonist indicated for the treatment of advanced prostate cancer. ( 1 )
5 WARNINGS AND PRECAUTIONS Tumor Flare: Transient increase in serum levels of testosterone during treatment may result in worsening of symptoms or onset of new signs and symptoms during the first few weeks of treatment, including bone pain, neuropathy, hematuria, bladder outlet obstruction,…
Manufacturer: URONOVA PHARMACEUTICALS, INC.
1 INDICATIONS AND USAGE Zoledronic acid injection is a bisphosphonate indicated for the treatment of: Hypercalcemia of malignancy. (1.1) Patients with multiple myeloma and patients with documented bone metastases from solid tumors, in conjunction with standard antineoplastic therapy. Prostate cancer should have progressed after treatment with at least one hormonal therapy. (1.2) Limitations of Use : The safety and efficacy of zoledronic acid injection has not been established for use in…
Recruiting trials that involve prostate cancer. Trial status changes often — always confirm with the trial coordinator before traveling.
No recruiting clinical trials are listed for this condition right now. Search ClinicalTrials.gov directly for the most current list.
A oncologist is typically the right starting point for prostate cancer.
Browse oncologists by city →No spam. Unsubscribe any time.
By subscribing you agree to our Privacy Policy. We will never share your data with third parties.
Skip the waiting room and connect with a licensed US doctor for prostate cancer questions and prescriptions where appropriate.
This page provides general health information for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
5 WARNINGS AND PRECAUTIONS Patients being treated with zoledronic acid injection should not be treated with Reclast ® . ( 5.1 ) Adequately rehydrate patients with hypercalcemia of malignancy prior to administration of zoledronic acid injection and monitor electrolytes during treatment. ( 5.2 )…
Manufacturer: Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
1 INDICATIONS AND USAGE Docetaxel Injection is a microtubule inhibitor indicated for: • Breast Cancer (BC): single agent for locally advanced or metastatic BC after chemotherapy failure; and with doxorubicin and cyclophosphamide as adjuvant treatment of operable node-positive BC ( 1.1 ) • Non-small Cell Lung Cancer (NSCLC): single agent for locally advanced or metastatic NSCLC after platinum therapy failure; and with cisplatin for unresectable, locally advanced or metastatic untreated NSCLC (…
BLACK BOX WARNING: WARNING: TOXIC DEATHS, HEPATOTOXICITY, NEUTROPENIA, HYPERSENSITIVITY REACTIONS, and FLUID RETENTION Treatment-related mortality associated with docetaxel is increased in patients with abnormal liver function, in patients receiving higher doses, and in patients with non-small…
Manufacturer: Hospira, Inc.
1 INDICATIONS AND USAGE RUBRACA is a poly (ADP-ribose) polymerase (PARP) inhibitor indicated: Ovarian cancer for the maintenance treatment of adult patients with a deleterious BRCA mutation (germline and/or somatic)-associated recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in a complete or partial response to platinum-based chemotherapy. ( 1.1 ) Prostate cancer for the treatment of adult patients with a deleterious BRCA mutation (germline and/or…
5 WARNINGS AND PRECAUTIONS Myelodysplastic Syndrome/Acute Myeloid Leukemia (MDS/AML): MDS/AML occurred in patients exposed to RUBRACA, and some cases were fatal. Monitor patients for hematological toxicity at baseline and monthly thereafter. Interrupt or reduce the dose based on severity of…
Manufacturer: pharmaand GmbH